直肠癌新辅助放化疗后晚期小肠毒性的剂量学预测参数
本研究纳入486例接受新辅助长程放化疗后手术的局部晚期直肠癌患者,评估小肠照射剂量-体积与晚期小肠毒性的关系并建立预测模型。中位随访60个月,7.4%发生≥2级、4.3%发生≥3级晚期小肠毒性;V30与小肠毒性关联最强,将V30限制在<200 cm3可将5年≥3级晚期小肠毒性控制在<5%。
要点
- V30是小肠晚期≥3级毒性关联最强的剂量学参数。
- 预测≥3级毒性5%风险的V30为201.5 cm3。
- 计划时将V30限制在<200 cm3可作为减少晚期毒性的参考。
核心结论
- 小肠接受至少30 Gy的体积(V30)与晚期≥3级小肠毒性显著相关,限制V30<200 cm3有助于将5年≥3级晚期小肠毒性控制在<5%。
研究设计与样本
- 单中心连续病例分析,纳入486例临床T3/T4或N1/N2的局部晚期直肠癌患者,均接受新辅助长程放化疗后手术且具备剂量学数据。
- 评估小肠照射与晚期小肠毒性的剂量-体积关系,并推导预测晚期小肠毒性的数学模型。
- 自放疗结束起中位随访60个月。
主要发现
- 36例(7.4%)发生≥2级晚期小肠毒性,21例(4.3%)发生≥3级晚期小肠毒性。
- 在5至40 Gy间每5 Gy间隔的各剂量水平上,≥3级晚期小肠毒性与受照小肠体积均呈统计学显著关联(所有剂量体积P < .001)。
- 发生≥2级毒性者平均小肠体积为2149.9 cm3,发生≥3级毒性者平均小肠体积为2179.9 cm3。
- V30与≥3级小肠毒性关联最强。
关键数值与推荐
- ≥2级小肠毒性5%风险对应的预测V30为101.5 cm3。
- ≥3级小肠毒性5%风险对应的预测V30为201.5 cm3。
- 计划时将V30限制在<200 cm3,以将5年≥3级晚期小肠毒性控制在<5%。
临床怎么用
- 直肠癌新辅助长程放化疗计划设计时,可将小肠V30<200 cm3作为剂量约束参考,以降低5年≥3级晚期小肠毒性风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to identify dosimetric parameters that predict late small bowel (SB) toxicity after neoadjuvant long course chemoradiation (CRT) for rectal cancer. METHODS AND MATERIALS: Four hundred eighty-six consecutive patients with locally advanced rectal cancers (clinical T3/T4 or N1/N2) who received CRT followed by surgery and had dosimetric data available for analysis were included in this study. The dose-volume relationship between small bowel irradiation and late small bowel toxicity was evaluated and a mathematical model to predict for late SB toxicity was derived. RESULTS: Among the 486 patients with a median follow-up of 60 months from completion of radiation, 36 (7.4%) patients experienced ≥ grade 2 and 21 (4.3%) developed ≥ grade 3 late SB toxicity. A statistically significant association between the development of grade ≥3 late small bowel toxicity and the volume of small bowel irradiated was found at each dose level from 5 to 40 Gy (P < .001 for all dose volumes) in 5 Gy intervals. The average SB volume for patients who experienced grade ≥2 SB toxicity was 2149.9 cm3 and the average SB volume for patients who experienced grade ≥3 SB toxicity was 2179.9 cm3. The predicted V30 for a 5% risk for grade ≥2 SB toxicity was 101.5 cm3 and for grade ≥3 SB toxicity was 201.5 cm3. The volume of small bowel receiving at least 30 Gy (V30) was most strongly associated with grade ≥3 SB toxicity. CONCLUSIONS: This study demonstrates the significant dose-volume relationship between volume of small bowel receiving 30 Gy (V30 Gy) and late grade ≥3 SB toxicity. When planning CRT for patients with rectal cancer, restricting V30 to <200 cm3 will be a useful guideline to minimize the 5 year grade ≥3 late SB toxicity to <5%.
引用
- Abraham AG, Usmani N, Warkentin B, et al. Dosimetric Parameters Predicting Late Small Bowel Toxicity in Patients With Rectal Cancer Receiving Neoadjuvant Chemoradiation. Pract Radiat Oncol. 2020. PMID: 32771626. doi:10.1016/j.prro.2020.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。